comparemela.com

Latest Breaking News On - Equity holdings private limited - Page 1 : comparemela.com

Stocks that will see action today: September 27, 2023 - The Hindu BusinessLine

Stocks that will see action today: September 27, 2023 - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Berhyanda Ltd gets nod for acquisition of up to 76 1% stake in Suven Pharmaceuticals Ltd

Berhyanda Ltd gets nod for acquisition of up to 76 1% stake in Suven Pharmaceuticals Ltd
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Suven Pharma Gets Nod For Acquisition Of Up To 76 1% Stake in the Company By Berhyanda Limited, Cyprus

Suven Pharma Gets Nod For Acquisition Of Up To 76 1% Stake in the Company By Berhyanda Limited, Cyprus
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

Suven Life Sciences Limited allots 1,81,00,000 convertible warrants

Suven Life Sciences Limited allots 1,81,00,000 convertible warrants Posted On: 2021-04-02 01:11:55 (Time Zone: Arizona, USA) In terms of the special resolution passed by the Members of Suven Life Sciences Limited at its Extra-Ordinary General Meeting held on 20th March, 2021 and in accordance with the In-principle approval granted by the NSE and BSE, the Board of Directors of the Company in its meeting held today i.e. 02nd April, 2021 has allotted 1,81,00,000 (One crore eighty one lakh) Warrants convertible into Equity Shares to Jasti Property and Equity Holdings Private Limited (In its capacity as sole trustee of Jasti Family Trust), promoter group entity at an issue price of Rs. 81.57/- per Warrant on preferential basis in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.